Literature DB >> 31074682

RNA sequencing in human HepG2 hepatocytes reveals PPAR-α mediates transcriptome responsiveness of bilirubin.

Darren M Gordon1, Thomas M Blomquist2, Scott A Miruzzi3, Robert McCullumsmith3, David E Stec4, Terry D Hinds1.   

Abstract

Bilirubin is a potent antioxidant that reduces inflammation and the accumulation of fat. There have been reports of gene responses to bilirubin, which was mostly attributed to its antioxidant function. Using RNA sequencing, we found that biliverdin, which is rapidly reduced to bilirubin, induced transcriptome responses in human HepG2 hepatocytes in a peroxisome proliferator-activated receptor (PPAR)-α-dependent fashion (398 genes with >2-fold change; false discovery rate P < 0.05). For comparison, a much narrower set of genes demonstrated differential expression when PPAR-α was suppressed via lentiviral shRNA knockdown (23 genes). Gene set enrichment analysis revealed the bilirubin-PPAR-α transcriptome mediates pathways for oxidation-reduction processes, mitochondrial function, response to nutrients, fatty acid oxidation, and lipid homeostasis. Together, these findings suggest that transcriptome responses from the generation of bilirubin are mostly PPAR-α dependent, and its antioxidant function regulates a smaller set of genes.

Entities:  

Keywords:  PPAR; biliverdin; gene; liver; transcription

Mesh:

Substances:

Year:  2019        PMID: 31074682      PMCID: PMC6620644          DOI: 10.1152/physiolgenomics.00028.2019

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  43 in total

1.  Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study.

Authors:  Jing-Ping Lin; Christopher J O'Donnell; Johannes P Schwaiger; L Adrienne Cupples; Arno Lingenhel; Steven C Hunt; Song Yang; Florian Kronenberg
Journal:  Circulation       Date:  2006-09-25       Impact factor: 29.690

Review 2.  Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin.

Authors:  Harvey A Schwertner; Libor Vítek
Journal:  Atherosclerosis       Date:  2008-03-17       Impact factor: 5.162

Review 3.  Bilirubin in the Liver-Gut Signaling Axis.

Authors:  Abdul-Rizaq Hamoud; Lauren Weaver; David E Stec; Terry D Hinds
Journal:  Trends Endocrinol Metab       Date:  2018-02-03       Impact factor: 12.015

Review 4.  Circulating bilirubin and defense against kidney disease and cardiovascular mortality: mechanisms contributing to protection in clinical investigations.

Authors:  Ai-Ching Boon; Andrew C Bulmer; Jeff S Coombes; Robert G Fassett
Journal:  Am J Physiol Renal Physiol       Date:  2014-04-23

Review 5.  Biliverdin reductase and bilirubin in hepatic disease.

Authors:  Lauren Weaver; Abdul-Rizaq Hamoud; David E Stec; Terry D Hinds
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-03-01       Impact factor: 4.052

6.  A Novel Fluorescence-Based Assay for the Measurement of Biliverdin Reductase Activity.

Authors:  Samuel O Adeosun; Kyle H Moore; David M Lang; Assumpta C Nwaneri; Terry D Hinds; David E Stec
Journal:  React Oxyg Species (Apex)       Date:  2018-01-01

7.  Bilirubin increases insulin sensitivity in leptin-receptor deficient and diet-induced obese mice through suppression of ER stress and chronic inflammation.

Authors:  Huansheng Dong; Hu Huang; Xinxu Yun; Do-sung Kim; Yinan Yue; Hongju Wu; Alton Sutter; Kenneth D Chavin; Leo E Otterbein; David B Adams; Young-Bum Kim; Hongjun Wang
Journal:  Endocrinology       Date:  2014-01-01       Impact factor: 4.736

8.  Biliverdin reductase, a novel regulator for induction of activating transcription factor-2 and heme oxygenase-1.

Authors:  Anatoliy Kravets; Zhenbo Hu; Tihomir Miralem; Michael D Torno; Mahin D Maines
Journal:  J Biol Chem       Date:  2004-02-25       Impact factor: 5.157

Review 9.  Therapeutic Efficacy of Stem Cells Transplantation in Diabetes: Role of Heme Oxygenase.

Authors:  Marco Raffaele; Giovanni Li Volti; Ignazio A Barbagallo; Luca Vanella
Journal:  Front Cell Dev Biol       Date:  2016-08-05

10.  Bilirubin Binding to PPARα Inhibits Lipid Accumulation.

Authors:  David E Stec; Kezia John; Christopher J Trabbic; Amarjit Luniwal; Michael W Hankins; Justin Baum; Terry D Hinds
Journal:  PLoS One       Date:  2016-04-12       Impact factor: 3.240

View more
  18 in total

1.  Bilirubin remodels murine white adipose tissue by reshaping mitochondrial activity and the coregulator profile of peroxisome proliferator-activated receptor α.

Authors:  Darren M Gordon; Kari L Neifer; Abdul-Rizaq Ali Hamoud; Charles F Hawk; Andrea L Nestor-Kalinoski; Scott A Miruzzi; Michael P Morran; Samuel O Adeosun; Jeffrey G Sarver; Paul W Erhardt; Robert E McCullumsmith; David E Stec; Terry D Hinds
Journal:  J Biol Chem       Date:  2020-05-13       Impact factor: 5.157

Review 2.  Bilirubin Safeguards Cardiorenal and Metabolic Diseases: a Protective Role in Health.

Authors:  Terry D Hinds; David E Stec
Journal:  Curr Hypertens Rep       Date:  2019-10-10       Impact factor: 5.369

Review 3.  Heme-oxygenase and lipid mediators in obesity and associated cardiometabolic diseases: Therapeutic implications.

Authors:  John A McClung; Lior Levy; Victor Garcia; David E Stec; Stephen J Peterson; Nader G Abraham
Journal:  Pharmacol Ther       Date:  2021-09-06       Impact factor: 12.310

Review 4.  Novel Function for Bilirubin as a Metabolic Signaling Molecule: Implications for Kidney Diseases.

Authors:  David E Stec; Claudio Tiribelli; Olufunto O Badmus; Terry D Hinds
Journal:  Kidney360       Date:  2022-03-25

Review 5.  Bilirubin as a metabolic hormone: the physiological relevance of low levels.

Authors:  Justin F Creeden; Darren M Gordon; David E Stec; Terry D Hinds
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-12-07       Impact factor: 4.310

6.  Bilirubin reduces visceral obesity and insulin resistance by suppression of inflammatory cytokines.

Authors:  Ryoko Takei; Tomoaki Inoue; Noriyuki Sonoda; Motoyuki Kohjima; Misato Okamoto; Ryuichi Sakamoto; Toyoshi Inoguchi; Yoshihiro Ogawa
Journal:  PLoS One       Date:  2019-10-02       Impact factor: 3.240

7.  Biliverdin Reductase A (BVRA) Knockout in Adipocytes Induces Hypertrophy and Reduces Mitochondria in White Fat of Obese Mice.

Authors:  David E Stec; Darren M Gordon; Andrea L Nestor-Kalinoski; Matthew C Donald; Zachary L Mitchell; Justin F Creeden; Terry D Hinds
Journal:  Biomolecules       Date:  2020-03-02

Review 8.  Role of Heme Oxygenase as a Modulator of Heme-Mediated Pathways.

Authors:  J Catharina Duvigneau; Harald Esterbauer; Andrey V Kozlov
Journal:  Antioxidants (Basel)       Date:  2019-10-11

9.  Cytochrome P450 1A2 Is Incapable of Oxidizing Bilirubin Under Physiological Conditions.

Authors:  Xinyi Li; Dongzhen Yu; Huiqun Jie; Huiqun Zhou; Haibo Ye; Guo Ma; Lili Wan; Chunyan Li; Haibo Shi; Shankai Yin
Journal:  Front Pharmacol       Date:  2019-10-18       Impact factor: 5.810

10.  The Effect of Silibinin on Protein Expression Profile in White Adipose Tissue of Obese Mice.

Authors:  Fei Wang; Shuchun Chen; Luping Ren; Yichao Wang; Zelin Li; Tiantian Song; He Zhang; Qiwen Yang
Journal:  Front Pharmacol       Date:  2020-02-28       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.